| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| 水杨酸苯酯 | phenyl Salicylate | 118-55-8 | C13H10O3 | 214.221 |
| 5-溴水杨酸 | 5-bromosalicyclic acid | 89-55-4 | C7H5BrO3 | 217.019 |
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| 5-溴-2-氨基甲酰氧基-苯甲酸苯基酯 | 5-Bromo-2-carbamoyloxy-benzoic acid phenyl ester | 122277-23-0 | C14H10BrNO4 | 336.142 |
| 5-溴水杨酸 | 5-bromosalicyclic acid | 89-55-4 | C7H5BrO3 | 217.019 |
As a part of our systematic study of antimycobacterially active derivatives of salicylamides, a series of nineteen derivatives of N-(2-pyridylmethyl)salicylamides and N-(3-pyridylmethyl)salicylamides was synthesised. The compounds exhibited in vitro activity against Mycobacterium tuberculosis and M. avium. Their lipophilicity, R M, was measured by thin layer chromatography on silica gel impregnated with trioctadecylsilane and the logarithm of the partition coefficient (octanol-water), logP, was calculated. Both the parameters of lipophilicity correlated. The quantitative relationship between the structure and antimycobacterial activity was calculated. Antimycobacterial activity increased with an increase in lipophilicity. The N-(2-pyridylmethyl)salicylamide derivatives were more active than the derivatives of isomeric N-(3-pyridylmethyl)salicylamides. The geometry of compounds was calculated and the calculation was verified by measuring the length of the hydrogen bond between hydroxyl and carbonyl groups on the salicylic moiety.